Macquarie Group
HZNP

Macquarie Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Macquarie Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,801
Closed -$902K – 1713
2023
Q3 		$902K Buy
7,801
+1,744
+29% +$187K ﹤0.01% 1363
2023
Q2 		$623K Sell
6,057
-2,772
-31% -$292K ﹤0.01% 1432
2023
Q1 		$964K Sell
8,829
-79,685
-90% -$8.81M ﹤0.01% 1366
2022
Q4 		$10.1M Sell
88,514
-1,719,050
-95% -$143M 0.01% 834
2022
Q3 		$112M Sell
1,807,564
-45,054
-2% -$3.15M 0.14% 191
2022
Q2 		$148M Sell
1,852,618
-84,649
-4% -$8.02M 0.17% 144
2022
Q1 		$204M Buy
1,937,267
+178,354
+10% +$17.4M 0.16% 128
2021
Q4 		$190M Buy
1,758,913
+132,842
+8% +$14.5M 0.16% 162
2021
Q3 		$178M Buy
1,626,071
+55,058
+4% +$5.72M 0.15% 161
2021
Q2 		$147M Buy
1,571,013
+1,561,546
+16,495% +$144M 0.12% 205
2021
Q1 		$872K Hold
9,467
– – ﹤0.01% 1426
2020
Q4 		$693K Buy
9,467
+1,210
+15% +$89.9K ﹤0.01% 1393
2020
Q3 		$641K Hold
8,257
– – ﹤0.01% 1346
2020
Q2 		$459K Sell
8,257
-1,043
-11% -$44.6K ﹤0.01% 1367
2020
Q1 		$275K Hold
9,300
– – ﹤0.01% 1386
2019
Q4 		$337K Buy
+9,300
New +$285K ﹤0.01% 1481
2019
Q2 		– Sell
-96,636
Closed -$2.55M – 1910
2019
Q1 		$2.55M Buy
96,636
+96,536
+96,536% +$2.29M ﹤0.01% 927
2018
Q4 		$2K Sell
100
-1,600
-94% -$31.4K ﹤0.01% 2222
2018
Q3 		$33K Sell
1,700
-17,300
-91% -$329K ﹤0.01% 1802
2018
Q2 		$315K Sell
19,000
-10,200
-35% -$156K ﹤0.01% 1510
2018
Q1 		$415K Buy
29,200
+16,300
+126% +$241K ﹤0.01% 1451
2017
Q4 		$188K Buy
12,900
+8,700
+207% +$122K ﹤0.01% 1747
2017
Q3 		$53K Buy
+4,200
New +$53.4K ﹤0.01% 2000

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Macquarie Group's HZNP Position: Q4 2023 in Review

Macquarie Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 7,801 shares — an estimated $902K sold.

Macquarie Group first reported a position in HZNP in Q3 2017 and held it in 23 quarters. The position peaked at $204M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Macquarie Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Macquarie Group sold 7,801 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $902K.
  • Macquarie Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2017 and held it in 23 quarters.
  • Macquarie Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $204M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Macquarie Group's 13F filing for Q4 2023, filed 14 Feb 2024.